“fda” Archives

in
Entry Author Date Location
OrthoPediatrics IPO Raises $52M for Medical Implants and Instruments 10/12/17 Indiana
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Five Questions For … Austin Biotech Entrepreneur Paul Lammers 09/29/17 Texas
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
FDA Panel Pans PTC’s Audacious Plan to Force Vote on Duchenne Drug 09/28/17 New York
Biomed Incubator Watershed Develops Tech for IDing Medical Devices 09/27/17 Texas
A4L Lands $25M for Imaging Tech that Reads Heart’s Electric Signals 09/27/17 Raleigh Durham
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Landos Joins Garabedian’s Bio Startup Accelerator Xontogeny, Gets $10M 09/21/17 Boston
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D 09/13/17 San Francisco
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
All Eyes on Depression Trials as Sage Neuro Drug Flunks Epilepsy Test 09/12/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others 09/07/17 New York
Presage Bio Licenses Anti-Cancer Drug to San Diego’s MEI Pharma 09/05/17 San Diego
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Gregor Joins Texas Accelerator to Advance Prostate Cancer Test 08/31/17 Wisconsin
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission 08/30/17 Indiana
Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed 08/30/17 San Diego
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
Page 2 of 65 « previous page · next page »